Audio podcasts featuring the week’s top medical news plus pertinent interviews
…
continue reading
Audio podcasts featuring the week’s top medical news plus pertinent interviews
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
14:08
14:08
Play later
Play later
Lists
Like
Liked
14:08
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
14:08
14:08
Play later
Play later
Lists
Like
Liked
14:08
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 301: Monkeypox — what to look for, how to treat
17:28
17:28
Play later
Play later
Lists
Like
Liked
17:28
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat. Included below is information for patients as well as links to some key articles…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 301: Monkeypox — what to look for, how to treat
17:28
17:28
Play later
Play later
Lists
Like
Liked
17:28
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat. Included below is information for patients as well as links to some key articles…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
9:32
9:32
Play later
Play later
Lists
Like
Liked
9:32
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patients with resectable stage III AB non-small cell lung cancer received n…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
9:32
9:32
Play later
Play later
Lists
Like
Liked
9:32
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patients with resectable stage III AB non-small cell lung cancer received n…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
14:58
14:58
Play later
Play later
Lists
Like
Liked
14:58
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the conference, Christine Sadlowski interviewed the presenter, Dr. Enrique…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
14:58
14:58
Play later
Play later
Lists
Like
Liked
14:58
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the conference, Christine Sadlowski interviewed the presenter, Dr. Enrique…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 297: Forget about all that vitamin D testing!!
12:59
12:59
Play later
Play later
Lists
Like
Liked
12:59
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The conclusion? “…providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 297: Forget about all that vitamin D testing!!
12:59
12:59
Play later
Play later
Lists
Like
Liked
12:59
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The conclusion? “…providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
29:38
29:38
Play later
Play later
Lists
Like
Liked
29:38
A VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE CLICK HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Your host is old enough to remember when hospital corridors featured physicians with little black bags, scurrying around to see their patients. That’s no longer true, of course. Most of the physicians seen in those corridors these days are white-co…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
29:38
29:38
Play later
Play later
Lists
Like
Liked
29:38
A VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE CLICK HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Your host is old enough to remember when hospital corridors featured physicians with little black bags, scurrying around to see their patients. That’s no longer true, of course. Most of the physicians seen in those corridors these days are white-co…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
15:45
15:45
Play later
Play later
Lists
Like
Liked
15:45
CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
15:45
15:45
Play later
Play later
Lists
Like
Liked
15:45
CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 294: PD-1 blockade in locally advanced rectal cancer
13:08
13:08
Play later
Play later
Lists
Like
Liked
13:08
Locally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiotherapy and then surgery. In a small-cohort study presented at this year’s ASCO conference researchers used a PD-1 inhibitor — dostarlimab — every three weeks for 6 months against the disease. All patients had mismatch repair deficient tumors. No o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 294: PD-1 blockade in locally advanced rectal cancer
13:08
13:08
Play later
Play later
Lists
Like
Liked
13:08
Locally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiotherapy and then surgery. In a small-cohort study presented at this year’s ASCO conference researchers used a PD-1 inhibitor — dostarlimab — every three weeks for 6 months against the disease. All patients had mismatch repair deficient tumors. No o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
11:24
11:24
Play later
Play later
Lists
Like
Liked
11:24
Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored the use of a monoclonal antibody–drug conjugate (trastuzumab–deruxtecan) in pat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
11:24
11:24
Play later
Play later
Lists
Like
Liked
11:24
Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored the use of a monoclonal antibody–drug conjugate (trastuzumab–deruxtecan) in pat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
14:40
14:40
Play later
Play later
Lists
Like
Liked
14:40
Apnea testing is part of the protocol used to determine whether a patient is dead according to neurologic criteria. The question is, do clinicians need to obtain consent to proceed? In a fascinating 15-minute chat, two intensivists, Drs. Patricia Kritek and Robert Truog, discuss that question and another, larger one: what is death, anyway? Their ba…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
14:40
14:40
Play later
Play later
Lists
Like
Liked
14:40
Apnea testing is part of the protocol used to determine whether a patient is dead according to neurologic criteria. The question is, do clinicians need to obtain consent to proceed? In a fascinating 15-minute chat, two intensivists, Drs. Patricia Kritek and Robert Truog, discuss that question and another, larger one: what is death, anyway? Their ba…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 291: Unionized nursing homes had lower mortality during Covid-19
13:16
13:16
Play later
Play later
Lists
Like
Liked
13:16
In the early waves of the Covid-19 pandemic why did patients in unionized nursing homes, have a roughly 10% lower rate of mortality than those in non-unionized ones? A report in Health Affairs tries to sort out the possible reasons. Listen to our 13-minute interview, which raises the question: Should you send your patients to non-unionized faciliti…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 291: Unionized nursing homes had lower mortality during Covid-19
13:16
13:16
Play later
Play later
Lists
Like
Liked
13:16
In the early waves of the Covid-19 pandemic why did patients in unionized nursing homes, have a roughly 10% lower rate of mortality than those in non-unionized ones? A report in Health Affairs tries to sort out the possible reasons. Listen to our 13-minute interview, which raises the question: Should you send your patients to non-unionized faciliti…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD
14:33
14:33
Play later
Play later
Lists
Like
Liked
14:33
The U.S. Preventive Services Task Force recently issued its sixth set of guidelines on using daily aspirin to prevent cardiovascular disease. The guidelines appeared in JAMA — whose editors asked our guest, Dr. Allan Brett, to write an editorial evaluation. This edition carries Brett’s advice on using the new guidelines in daily clinical practice. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD
14:33
14:33
Play later
Play later
Lists
Like
Liked
14:33
The U.S. Preventive Services Task Force recently issued its sixth set of guidelines on using daily aspirin to prevent cardiovascular disease. The guidelines appeared in JAMA — whose editors asked our guest, Dr. Allan Brett, to write an editorial evaluation. This edition carries Brett’s advice on using the new guidelines in daily clinical practice. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 289: Saline versus balanced crystalloids — what to choose
16:22
16:22
Play later
Play later
Lists
Like
Liked
16:22
Saline or balanced crystalloids? The question of which resuscitation fluid to use in clinical practice seems to have been settled by recent research findings — or at least settled in favor of balanced crystalloids. But wait, our guests see slight differences that may affect your choice. Patricia Kritek practices critical care medicine at the Univer…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Podcast 289: Saline versus balanced crystalloids — what to choose
16:22
16:22
Play later
Play later
Lists
Like
Liked
16:22
Saline or balanced crystalloids? The question of which resuscitation fluid to use in clinical practice seems to have been settled by recent research findings — or at least settled in favor of balanced crystalloids. But wait, our guests see slight differences that may affect your choice. Patricia Kritek practices critical care medicine at the Univer…
…
continue reading